Advance Legend Biotech's interests with respect to educating member of Congress on the importance of the role of biotechnology in healthcare
2025 · 4th Quarter (Oct 1 - Dec 31)
LEGEND BIOTECH CORPORATION
Filed by HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP).
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 20, 2026
- Income
- $90,000.00
- Expenses
- Not reported
- Filing UUID
- 3db4ff82-c908-4236-b511-db9400d19622
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.